title: Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation.
authors.affiliation: Sydney Medical School, Concord Clinical School, The University of Sydney, Concord, NSW 2139, Australia Department of Cardiology and Anzac Research Institute, Concord Hospital 3W, The University of Sydney, Hospital Rd, Concord, NSW 2139, Australia ben.freedman@sydney.edu.au.
authors.forename: S
authors.initials: S
authors.lastname: Ben Freedman
authors.affiliation: Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN, USA.
authors.forename: Bernard J
authors.initials: BJ
authors.lastname: Gersh
authors.affiliation: University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK Aalborg University, Aalborg, Denmark.
authors.forename: Gregory Y H
authors.initials: GY
authors.lastname: Lip
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001294:Attitude to Health; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D011639:Public Opinion; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin